Kwon Y - Search Results

1

The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study.

Jung SY, Jeong J, Shin SH, Kwon Y, Kim EA, Ko KL, Shin KH, Lee KS, Park IH, Lee S, Kim SW, Kang HS, Ro J. Jung SY, et al. Among authors: kwon y. BMC Cancer. 2010 Dec 3;10:664. doi: 10.1186/1471-2407-10-664. BMC Cancer. 2010. PMID: 21126378 Free PMC article.

2

Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor beta but not the estrogen receptor alpha gene.

Chang HG, Kim SJ, Chung KW, Noh DY, Kwon Y, Lee ES, Kang HS. Chang HG, et al. Among authors: kwon y. J Mol Med (Berl). 2005 Feb;83(2):132-9. doi: 10.1007/s00109-004-0596-2. Epub 2004 Nov 5. J Mol Med (Berl). 2005. PMID: 15536519

3

Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy.

Kang SH, Kim SK, Kwon Y, Kang HS, Kang JH, Ro J, Lee ES. Kang SH, et al. Among authors: kwon y. World J Surg. 2004 Oct;28(10):1019-24. doi: 10.1007/s00268-004-7367-7. Epub 2004 Sep 29. World J Surg. 2004. PMID: 15573258 Clinical Trial.

4

Predicting tissue HER2 status using serum HER2 levels in patients with metastatic breast cancer.

Kong SY, Nam BH, Lee KS, Kwon Y, Lee ES, Seong MW, Lee DH, Ro J. Kong SY, et al. Among authors: kwon y. Clin Chem. 2006 Aug;52(8):1510-5. doi: 10.1373/clinchem.2006.067512. Epub 2006 Jun 15. Clin Chem. 2006. PMID: 16777917

5

Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients.

Lee S, Kim EY, Kang SH, Kim SW, Kim SK, Kang KW, Kwon Y, Shin KH, Kang HS, Ro J, Lee ES. Lee S, et al. Among authors: kwon y. Breast Cancer Res Treat. 2007 May;102(3):283-8. doi: 10.1007/s10549-006-9330-9. Epub 2006 Oct 25. Breast Cancer Res Treat. 2007. PMID: 17063280 Clinical Trial.

6

Primary malignant teratoma with a primitive neuroectodermal tumor component in thyroid gland: a case report.

Kim E, Bae TS, Kwon Y, Kim TH, Chung KW, Kim SW, Ro J, Lee ES. Kim E, et al. Among authors: kwon y. J Korean Med Sci. 2007 Jun;22(3):568-71. doi: 10.3346/jkms.2007.22.3.568. J Korean Med Sci. 2007. PMID: 17596674 Free PMC article.

7

A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer.

Lee KS, Ro J, Nam BH, Lee ES, Kwon Y, Kwon HS, Chung KW, Kang HS, Kim EA, Kim SW, Shin KH, Kim SK. Lee KS, et al. Among authors: kwon y, kwon hs. Breast Cancer Res Treat. 2008 Jun;109(3):481-9. doi: 10.1007/s10549-007-9672-y. Epub 2007 Jul 26. Breast Cancer Res Treat. 2008. PMID: 17653851 Clinical Trial.

8

Breast cancer subtypes and survival in patients with brain metastases.

Nam BH, Kim SY, Han HS, Kwon Y, Lee KS, Kim TH, Ro J. Nam BH, et al. Among authors: kwon y. Breast Cancer Res. 2008;10(1):R20. doi: 10.1186/bcr1870. Epub 2008 Feb 28. Breast Cancer Res. 2008. PMID: 18307763 Free PMC article.

9

Major response to sunitinib (Sutene) in metastatic malignant phyllodes tumor of breast.

Park IH, Kwon Y, Kim EA, Lee KS, Ro J. Park IH, et al. Among authors: kwon y. Invest New Drugs. 2009 Aug;27(4):387-8. doi: 10.1007/s10637-008-9195-3. Epub 2008 Nov 11. Invest New Drugs. 2009. PMID: 19002383 No abstract available.

10

Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer: a phase II trial.

Lee KS, Ro J, Lee ES, Kang HS, Kim SW, Nam BH, Kwon Y, Kim EA, Shin KH. Lee KS, et al. Among authors: kwon y. Invest New Drugs. 2010 Feb;28(1):83-90. doi: 10.1007/s10637-009-9229-5. Epub 2009 Feb 20. Invest New Drugs. 2010. PMID: 19229476 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,183 results

Search Page

Filters